Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines

Yasushi Adachi, Choon Taek Lee, Keith Coffee, Noboru Yamagata, Joyce E. Ohm, Kyung Ho Park, Mikhail M. Dikov, Sorena R. Nadaf, Carlos L. Arteaga, David P. Carbone

Research output: Contribution to journalArticle

84 Scopus citations

Abstract

Background & Aims: Insulin-like growth factor (IGF)-I receptor (IGF-Ir) signaling is required for maintenance of growth and tumorigenicity of several tumor types. We have previously shown successful therapy in a lung cancer xenograft model using an adenovirus expressing antisense IGF-Ir. In this study, we sought to better dissect the mechanism and develop potentially more effective IGF-Ir-targeted therapeutics by developing and testing tetracycline-regulated and recombinant adenoviruses expressing dominant negative receptors. Methods: Truncated IGF-I receptors (IGF-Ir/tf; 482 and 950 amino acids long, respectively [IGF-Ir/482st and IGF-Ir/950st]) were cloned into tetracycline-regulated vectors and recombinant adenoviruses and then studied in colorectal cancer cells. We assessed the effect of IGF-Ir/tf on signaling blockade, colony formation, stress response (serum starvation and heat), chemotherapy-induced apoptosis, and in vivo therapeutic efficacy in xenografts. Results: Activation of IGF-Ir/tf expression by withdrawal of tetracycline suppressed tumorigenicity both in vitro and in vivo and up-regulated stressor-induced apoptosis. It effectively blocked both IGF-I- and IGF-II-induced activation of Akt-1. IGF-Ir/tf expression increased chemotherapy-induced apoptosis, and this combination therapy was very effective against tumors in mice. These findings were confirmed in a therapy model against established tumors using adenoviruses expressing IGF-Ir/tf. Moreover, IGF-Ir/482st was more effective than IGF-Ir/950st because of its bystander effect. Conclusions: Anti-tumor activity of IGF-Ir/tf is mediated through inhibition of Akt-1 and enhances the efficacy of chemotherapy. Adenovirus IGF-Ir/482st may be a useful anticancer therapeutic for colorectal carcinoma.

Original languageEnglish (US)
Pages (from-to)1191-1204
Number of pages14
JournalGastroenterology
Volume123
Issue number4
DOIs
StatePublished - Oct 2002

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines'. Together they form a unique fingerprint.

  • Cite this

    Adachi, Y., Lee, C. T., Coffee, K., Yamagata, N., Ohm, J. E., Park, K. H., Dikov, M. M., Nadaf, S. R., Arteaga, C. L., & Carbone, D. P. (2002). Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology, 123(4), 1191-1204. https://doi.org/10.1053/gast.2002.36023